Scaling back Florida’s AIDS Drug Assistance Program could mean a resurgence of HIV/AIDS and increased health care costs throughout the state.
Articles on HIV/AIDS and drugs
Displaying all articles
The US cuts in research funding are devastating to the fight against HIV/Aids. It’s going to be very hard to recover.
Africa’s investment into research and development is far below the global average.
Aids was first identified 40 years ago: these are the game changers that have revolutionised treatment – and the obstacles that remain.
The FDA receives almost half its funding from companies it regulates, such as drug and medical device makers. Is this something you should be concerned about?
Top contributors
-
Distinguished Professor, Infectious Disease and Oncology Research Institute, Faculty of Heath Sciences, University of the Witwatersrand, Executive Director Perinatal HIV Research Unit, Chief Scientific Officer, South African Medical Research Council
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
-
Chief Scientific Officer, Desmond Tutu Health Foundation and Senior Researcher, University of the Witwatersrand
-
Acting Instructor of Medicine, University of Washington
-
Professor Emeritus, College of Medicine, Florida State University